These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2469790)

  • 1. SK&F 93574, a histamine H2-receptor antagonist, releases histamine in the dog.
    Jones CA; Conybeare G; Mortensen A; Catto LC; Atterwill CK
    J Pharm Pharmacol; 1989 Jan; 41(1):68-71. PubMed ID: 2469790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by SK&F 93479 against the haemodynamic effects of coronary artery ligation in dogs.
    Dai S
    Pharmacol Res Commun; 1984 Oct; 16(10):987-98. PubMed ID: 6150499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors.
    Harvey CA; Owen DA
    Br J Pharmacol; 1984 Oct; 83(2):427-32. PubMed ID: 6148984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SK&F 93479 on experimentally induced ventricular arrhythmias in dogs, rats and mice.
    Dai S
    Agents Actions; 1984 Oct; 15(3-4):131-6. PubMed ID: 6151803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SK&F 93944 (Temelastine), a potent histamine H1-receptor antagonist in pharmacologic and antigen-induced bronchoconstriction.
    Malo PE; Muccitelli R; Tucker SS; Wasserman MA
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):461-8. PubMed ID: 2875234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog.
    Masini E; Planchenault J; Pezziardi F; Gautier P; Gagnol JP
    Agents Actions; 1985 Sep; 16(6):470-7. PubMed ID: 2416204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated pentagastrin-stimulated gastric acid secretory tests carried out in the evaluation of the pharmacodynamics of a new histamine H2-receptor antagonist, SK&F 93479.
    Jönsson KA; Bodemar G; Norlander B; Walan A
    Scand J Gastroenterol; 1984 Mar; 19(2):209-15. PubMed ID: 6144180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H1- and H2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study.
    Kimura K; Adachi M; Kubo K
    Inflamm Res; 1999 Mar; 48(3):128-32. PubMed ID: 10219654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system.
    Brown EA; Griffiths R; Harvey CA; Owen DA
    Br J Pharmacol; 1986 Mar; 87(3):569-78. PubMed ID: 2879585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assay of a novel histamine H2-receptor antagonist, SK&F 93479, in human plasma by normal-phase high-performance liquid chromatography.
    McDowall RD; Lee RM
    J Chromatogr; 1983 Jul; 275(2):377-85. PubMed ID: 6137490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cimetidine with new H2-antagonists in rabbit and guinea pig gastric cells.
    Batzri S; Harmon JW; Toles R
    Eur J Pharmacol; 1983 Oct; 94(1-2):1-8. PubMed ID: 6140169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
    Sivelle PC; Underwood AH; Jelly JA
    Biochem Pharmacol; 1982 Mar; 31(5):677-84. PubMed ID: 6123322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation.
    Hosking MP; Lennon RL; Gronert GA
    Anesth Analg; 1988 Nov; 67(11):1089-92. PubMed ID: 2461127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models with clinically-relevant and life-threatening histamine-related cardiovascular disturbances: evaluation of the clinical effectiveness of H1/H2-histamine receptor antagonists in perioperative histamine release.
    Künneke M; Stinner B; Duda D; Hasse C; Lorenz W
    Inflamm Res; 1996 Mar; 45 Suppl 1():S44-5. PubMed ID: 8696924
    [No Abstract]   [Full Text] [Related]  

  • 15. Histamine lipolysis I: changes in the free fatty acid levels of dog plasma after intravenous infusion of histamine.
    Akiyama Y; Mukai T; Kamei C; Tasaka K
    Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):315-24. PubMed ID: 1977972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion of H2-antagonist equilibrium constants by uptake in rabbit gastric mucosal cells.
    Batzri S; Thompson WF; Toles R
    Pharmacology; 1985; 30(4):215-24. PubMed ID: 2859616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.
    Davies BE; Minthorn EA; Dennis MJ; Rosing H; Beijnen JH
    Pharm Res; 1997 Oct; 14(10):1461-5. PubMed ID: 9358562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of H2 receptor antagonists on the hepatotoxicity of various chemicals.
    Leonard TB; Dent JG
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):375-88. PubMed ID: 6147001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of histamine release during constant rate infusion of morphine in dogs.
    Guedes AG; Rudé EP; Rider MA
    Vet Anaesth Analg; 2006 Jan; 33(1):28-35. PubMed ID: 16412130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.